Drägerwerk AG & Co. KGaA (ETR:DRW3)

Market Cap	1.76B +54.1%
Revenue (ttm)	3.57B +6.4%
Net Income	171.28M +71.5%
EPS	9.13 +71.5%
Shares Out	18.76M
PE Ratio	11.96
Forward PE	12.50
Dividend	2.27 (2.06%)
Ex-Dividend Date	May 11, 2026

Volume	5,874
Open	109.40
Previous Close	109.20
Day's Range	108.80 - 110.00
52-Week Range	62.50 - 114.20
Beta	0.63
Analysts	Buy
Price Target	105.00 (-4.37%)
Earnings Date	Jul 30, 2026

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1889
• Employees: 16,009
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DRW3

Financial Performance

In 2025, Drägerwerk AG & Co. KGaA's revenue was 3.48 billion, an increase of 3.29% compared to the previous year's 3.37 billion. Earnings were 139.50 million, an increase of 12.13%.

Analyst Summary

According to 5 analysts, the average rating for DRW3 stock is "Buy." The 12-month stock price target is €105.00, which is a decrease of -4.37% from the latest price.

Price Target

€105.00

(-4.37% downside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 18, 2026

Data Sources Report a data error